The closing price of AdaptHealth Corp (NASDAQ: AHCO) was $10.48 for the day, up 1.06% from the previous closing price of $10.37. In other words, the price has increased by $+0.11 from its previous closing price. On the day, 853915 shares were traded. AHCO stock price reached its highest trading level at $10.58 during the session, while it also had its lowest trading level at $10.29.
Ratios:
Our analysis of AHCO’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.73. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.21. In the meantime, Its Debt-to-Equity ratio is 1.57 whereas as Long-Term Debt/Eq ratio is at 1.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’23 when Williams David Solomon III sold 2,255 shares for $9.30 per share. The transaction valued at 20,972 led to the insider holds 29,779 shares of the business.
SkyKnight Aero Holdings, LLC sold 137,787 shares of AHCO for $1,931,085 on Aug 11 ’23. The Director now owns 2,815,117 shares after completing the transaction at $14.02 per share. On Aug 11 ’23, another insider, SkyKnight Aero Holdings, LLC, who serves as the Director of the company, sold 59,052 shares for $14.02 each. As a result, the insider received 827,614 and left with 5,565,126 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1.38B and an Enterprise Value of 3.60B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 0.95. Its current Enterprise Value per Revenue stands at 1.12 whereas that against EBITDA is -17.07.
Stock Price History:
Over the past 52 weeks, AHCO has reached a high of $15.90, while it has fallen to a 52-week low of $6.37. The 50-Day Moving Average of the stock is 7.55, while the 200-Day Moving Average is calculated to be 9.52.
Shares Statistics:
AHCO traded an average of 1.31M shares per day over the past three months and 1.8M shares per day over the past ten days. A total of 132.63M shares are outstanding, with a floating share count of 71.99M. Insiders hold about 45.83% of the company’s shares, while institutions hold 58.06% stake in the company. Shares short for AHCO as of Feb 15, 2024 were 9.23M with a Short Ratio of 7.05, compared to 9.88M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.96% and a Short% of Float of 8.92%.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of $0.06 for the current quarter, with a high estimate of $0.09 and a low estimate of $0.03, while EPS last year was $0.11. The consensus estimate for the next quarter is $0.21, with high estimates of $0.24 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.93 and $0.69 for the fiscal current year, implying an average EPS of $0.85. EPS for the following year is $1.09, with 7 analysts recommending between $1.31 and $0.93.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 9 analysts. It ranges from a high estimate of $784.9M to a low estimate of $767M. As of the current estimate, AdaptHealth Corp’s year-ago sales were $744.63M, an estimated increase of 3.40% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $821.78M, an increase of 3.60% over than the figure of $3.40% in the same quarter last year. There is a high estimate of $829.62M for the next quarter, whereas the lowest estimate is $813.1M.
A total of 9 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.35B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.32B. In the same quarter a year ago, actual revenue was $3.2B, up 3.70% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $3.52B in the next fiscal year. The high estimate is $3.66B and the low estimate is $3.45B. The average revenue growth estimate for next year is up 6.20% from the average revenue estimate for this year.
